Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Myelofibrosis
Closed
Phase 1
This trial is looking at 2 drugs called ruxolitinib (pronounced ruck-sol-it-in-ib) and BKM120 to treat myelofibrosis.
Recruitment start: 7 January 2013
Recruitment end: 19 February 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Claire Harrison
Experimental Cancer Medicine Centre (ECMC)
Novartis
Last reviewed: 15 February 2016
CRUK internal database number: 10694
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
